Skip to main content

CITIGROUP INC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 831001 NEW YORK, NY

Position in RXRX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$3,172,358
+$2,611,746 QoQ
Shares Held
864,403
+373.4% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Derivatives in RXRX

reported options exposure · as of Jun 30, 2026
CallValue
$330,300
CallShares
90,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. RXRX ranks #89 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXRX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,172,358 864,403
2026-06-30 $330,300 90,000
2026-03-31 $560,612 182,610
2025-12-31 $696,473 170,287
2025-12-31 $122,700 30,000
2025-12-31 $122,700 30,000
2025-09-30 $324,036 66,401
2025-06-30 $1,086,618 214,747
2025-03-31 $3,488,483 659,449
2024-12-31 $3,386,677 500,988
2024-12-31 $149,396 22,100
2024-12-31 $149,396 22,100
2024-09-30 $1,257,054 190,752
2024-06-30 $777,074 103,610
2024-03-31 $7,987,833 801,187
2024-03-31 $625,119 62,700
2023-12-31 $3,991,850 404,853
2023-09-30 $3,599,416 470,512
2023-06-30 $1,324,713 177,338
2023-03-31 $4,590,460 688,225
2022-12-31 $1,795,096 232,827
2022-09-30 $1,718,997 161,560
2022-06-30 $100,121 12,300
2022-03-31 $106,676 14,899
2021-12-31 $4,185,835 244,357
2021-09-30 $1,042,214 45,294
2021-06-30 $36,719 1,006